US 12,486,229 B2
Indole derivative and application thereof
Feng Ren, Shanghai (CN); Yubin Lv, Shanghai (CN); Hailong Wang, Shanghai (CN); Yueying Ren, Shanghai (CN); Chunlin Chen, Shanghai (CN); Yangchun Luo, Shanghai (CN); Jinna Cai, Shanghai (CN); and Bangliang Li, Shanghai (CN)
Assigned to SHANGHAI MEDICILON INC., Shanghai (CN)
Appl. No. 18/013,688
Filed by SHANGHAI MEDICILON INC., Shanghai (CN)
PCT Filed Jul. 2, 2021, PCT No. PCT/CN2021/104138
§ 371(c)(1), (2) Date Dec. 29, 2022,
PCT Pub. No. WO2022/002225, PCT Pub. Date Jan. 6, 2022.
Claims priority of application No. 202010638390.0 (CN), filed on Jul. 3, 2020.
Prior Publication US 2023/0357148 A1, Nov. 9, 2023
Int. Cl. C07D 209/32 (2006.01); A61P 1/06 (2006.01)
CPC C07D 209/32 (2013.01) [A61P 1/06 (2018.01)] 3 Claims
OG exemplary drawing
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry